Title : Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in breast cancer: current status and future development.

Pub. Date : 2005 Sep 1

PMID : 15970523






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In addition, preclinical and clinical findings support the use of EGFR TKIs in specific subgroups of breast cancer patients, such as estrogen receptor positive (ER+), tamoxifen resistant patients. Tamoxifen epidermal growth factor receptor Homo sapiens